206 related articles for article (PubMed ID: 30762282)
21. Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sparber-Sauer M; Seitz G; von Kalle T; Vokuhl C; Leuschner I; Scheer M; Münter M; Ljungman G; Bielack SS; Niggli F; Ladenstein R; Klingebiel T; Fuchs J; Koscielniak E;
Pediatr Blood Cancer; 2018 May; 65(5):e26943. PubMed ID: 29316163
[TBL] [Abstract][Full Text] [Related]
22. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
Viswanathan AN; Grier HE; Litman HJ; Perez-Atayde A; Tarbell NJ; Neuberg D; Shamberger RC; Marcus KJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1208-14. PubMed ID: 15001265
[TBL] [Abstract][Full Text] [Related]
23. Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas?
Mattke AC; Bailey EJ; Schuck A; Dantonello T; Leuschner I; Klingebiel T; Treuner J; Koscielniak E
Pediatr Blood Cancer; 2009 Jul; 52(7):772-6. PubMed ID: 19165889
[TBL] [Abstract][Full Text] [Related]
24. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
[TBL] [Abstract][Full Text] [Related]
25. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
[TBL] [Abstract][Full Text] [Related]
26. Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology.
Martelli H; Oberlin O; Rey A; Godzinski J; Spicer RD; Bouvet N; Haie-Meder C; Terrier-Lacombe MJ; Sanchez de Toledo J; Spooner D; Sommelet D; Flamant F; Stevens MC
J Clin Oncol; 1999 Jul; 17(7):2117-22. PubMed ID: 10561266
[TBL] [Abstract][Full Text] [Related]
27. Outcome of localized liver-bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG)-RMS 2005 study.
Guérin F; Rogers T; Minard-Colin V; Gaze MN; Terwisscha S; Van Noesel M; De Corti F; Guillén Burrieza G; De Salvo GL; Kelsey A; Orbach D; Ferrari A; Bergeron C; Bisogno G; Martelli H
Pediatr Blood Cancer; 2019 Jul; 66(7):e27725. PubMed ID: 30920113
[TBL] [Abstract][Full Text] [Related]
28. Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience.
Pondrom M; Bougeard G; Karanian M; Bonneau-Lagacherie J; Boulanger C; Boutroux H; Briandet C; Chevreau C; Corradini N; Coze C; Defachelles AS; Galmiche-Roland L; Orbach D; Piguet C; Scoazec JY; Vérité C; Willems M; Frebourg T; Minard V; Brugières L
Pediatr Blood Cancer; 2020 Sep; 67(9):e28486. PubMed ID: 32658383
[TBL] [Abstract][Full Text] [Related]
29. [Rhabdomyosarcoma in the area of the head-neck. A synopsis of some cases, therapeutic possibilities and prognoses].
Hess A; Schröder U; Schröder R; Michel O
Laryngorhinootologie; 1998 Oct; 77(10):557-63. PubMed ID: 9842519
[TBL] [Abstract][Full Text] [Related]
30. Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
Winter S; Fasola S; Brisse H; Mosseri V; Orbach D
Pediatr Blood Cancer; 2015 Nov; 62(11):1935-41. PubMed ID: 26150380
[TBL] [Abstract][Full Text] [Related]
31. Rhabdomyosarcoma in infants younger than one year old: a report from the Italian Cooperative Group.
Ferrari A; Casanova M; Bisogno G; Zanetti I; Cecchetto G; De Bernardi B; Riccardi R; Tamaro P; Meazza C; Alaggio R; Ninfo V; Carli M;
Cancer; 2003 May; 97(10):2597-604. PubMed ID: 12733159
[TBL] [Abstract][Full Text] [Related]
32. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
[TBL] [Abstract][Full Text] [Related]
33. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
Ruymann FB; Grovas AC
Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
[TBL] [Abstract][Full Text] [Related]
34. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V
Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612
[TBL] [Abstract][Full Text] [Related]
35. Urachal rhabdomyosarcoma in childhood: a rare entity with a poor outcome.
Cheikhelard A; Irtan S; Orbach D; Minard-Colin V; Rod J; Martelli H; Sarnacki S
J Pediatr Surg; 2015 Aug; 50(8):1329-33. PubMed ID: 25913896
[TBL] [Abstract][Full Text] [Related]
36. Malignant peripheral nerve sheath tumors in children, adolescents, and young adults: Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Meister MT; Scheer M; Hallmen E; Stegmaier S; Vokuhl C; von Kalle T; Fuchs J; Münter M; Niggli F; Ladenstein R; Kazanowska B; Ljungman G; Bielack S; Koscielniak E; Klingebiel T;
J Surg Oncol; 2020 Dec; 122(7):1337-1347. PubMed ID: 32812260
[TBL] [Abstract][Full Text] [Related]
37. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma.
Weigel BJ; Breitfeld PP; Hawkins D; Crist WM; Baker KS
J Pediatr Hematol Oncol; 2001; 23(5):272-6. PubMed ID: 11464981
[TBL] [Abstract][Full Text] [Related]
38. Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma?
Lin JL; Guillerman RP; Russell HV; Lupo PJ; Nicholls L; Okcu MF
Pediatr Blood Cancer; 2016 Feb; 63(2):202-5. PubMed ID: 26376023
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of orbital rhabdomyosarcoma in children in Japan.
Takahashi N; Minoda K
Jpn J Ophthalmol; 1991; 35(3):292-9. PubMed ID: 1770669
[TBL] [Abstract][Full Text] [Related]
40. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group.
Pappo AS; Anderson JR; Crist WM; Wharam MD; Breitfeld PP; Hawkins D; Raney RB; Womer RB; Parham DM; Qualman SJ; Grier HE
J Clin Oncol; 1999 Nov; 17(11):3487-93. PubMed ID: 10550146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
